Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Medical Solutions ( (GB:AMS) ) has provided an announcement.
Advanced Medical Solutions Group has published its Annual Report and Accounts for the year ended 31 December 2025 and has dispatched these documents, together with the notice of its upcoming Annual General Meeting, to shareholders. The AGM is scheduled for 17 June 2026 in London, with all related materials, including the proxy form and meeting notice, made available on the company’s website, underlining its ongoing emphasis on shareholder communication and governance transparency.
The release highlights that AMS continues to leverage its scalable, diversified business model and the integration of Peters Surgical to drive operational and commercial synergies. With surgical products now contributing the majority of group revenues and an increasing proportion of sales routed through direct sales teams, the company signals its positioning for continued growth and long-term value creation for investors and other stakeholders.
The most recent analyst rating on (GB:AMS) stock is a Hold with a £260.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.
Spark’s Take on AMS Stock
According to Spark, TipRanks’ AI Analyst, AMS is a Neutral.
The score is driven primarily by mixed fundamentals: improving recent revenue and cash flow, but materially weaker profitability versus prior peaks and higher leverage. Technicals are supportive due to a strong uptrend, though momentum is overextended. Valuation is the biggest drag given the high P/E and only modest dividend yield.
To see Spark’s full report on AMS stock, click here.
More about Advanced Medical Solutions
Advanced Medical Solutions Group is a UK-based medical device company specialising in tissue-healing technologies, including adhesives, sealants, biosurgical devices and sutures. The group focuses on combining advanced material science with applicator design to deliver differentiated surgical products, and is expanding internationally, particularly in the U.S., following its acquisition of Peters Surgical.
Average Trading Volume: 1,211,006
Technical Sentiment Signal: Strong Buy
Current Market Cap: £554M
Learn more about AMS stock on TipRanks’ Stock Analysis page.